Adverum Biotechnologies Inc (ADVM)

[DewDiligence]

AAVL’s CEO calls it quits:

http://money.cnn.com/news/newsfeeds/articles/globenewswire/10142889.htm

[rivervalley]

time to get back into the 17's. AAVL

[rivervalley]

nice way to end the week. Have to believe shorts will start covering all those shares soon....or risk covering much higher.

[rivervalley]

nice green day yesterday for AAVL. Hopefully a nice rebound here over the next few months.

[rivervalley]

after flipping this one twice for a small gain both times I've started accumulating shares again-once I see it gain some steam instead of stall out I would like to hold shares for a much higher price. Would need a pass and hold of 17.00 first.

[rivervalley]

like to see a pass and hold of 17.00 today.

[Jean Ralphio]

Buy low sell high. This stock's way below market value, just waiting for the bounce back. Holding out for more info on possible acquisition

[rivervalley]

filled the gap from earlier this morning, now it can start up again hopefully :)

[Jack30]

Avalanche Biotechnologies (AAVL) upgraded to Neutral at Chardan Capital Markets; tgt $20
8:57 AM ET 6/23/15


Chardan Capital Markets upgrades AAVL to Neutral from Sell and sets target price at $20 noting they feel that recent share price movements may have been overdone. Firm does not see much scope for co to trade well below recent prices ($15-$16), given: 1) the $11.50 cash per share position, 2) their belief in the importance of gene therapy, per their prior research, and 3) the likelihood that M&A interest in Avalanche could pick up given the cash position and given the interest already shown by adept bigger-cap players in the space. Although upside from here to their $20 price target would normally qualify co for a Buy rating, firm looks for further visibility and/or confirmation on AVA-101 NT catalysts that could take the stock to $20.

[rivervalley]

some back to back green days would be great. I like the action here today. Hopefully bottom is already in.

[Jack30]

We should start seeing several days of green here. This stock has to rebound from lows here.

[rivervalley]

need a strong last hr here. Great day to this point.

[rivervalley]

back in with a few 16.12's.

[rivervalley]

flipped that first batch as well. Looks like a lot of folks did, and it pushed pps back down for hopefully another run. Just hope this 17 bottom doesn't break.

[lvhd]

Back in 17.10

[rivervalley]

up 7% now, HOD 18.38. With the low float this could get interesting.

[rivervalley]

18.13 HOD so far, looking good.

[rivervalley]

initiated a starter here late yesterday afternoon.

[shankapotamus]

$AAVL: http://thebagholderdiaries.blogspot.com/2015/06/aavl-buries-longs-562.html

[DewDiligence]

There were plenty of them on Twitter, LOL.

[gixxer11]

Not a single Avalanche pun today

[DewDiligence]

AAVL CC post-mortem: #msg-114639372.

[KingDMC]

Explains all he insider selling here...

[PAC]

AAVL 19.4 -50% some research firms maintain bullish outlook. Looking for bounce

[DewDiligence]

Notes on today's CC and AH price drop: #msg-114621453.

[lgonber]

http://www.thestreet.com/story/13182199/1/avalanche-bio-gene-therapy-preview-what-to-expect-from-eye-study.html

[GuTA]

Yep. Just noise for now. Still think it's $50+ this summer

[lgonber]

Agree. i am expecting news at the beginning of July. Since then, trading in a tight range. I have not seen any news that prompted the up on Friday or the down yesterday.

[GuTA]

Still would hold through news. Today was a rough day in general and this has shown to be a wild horse lately. Could be back over 40 by end if week. Just in a broad and volatile range right now

[lgonber]

What is your take on today drop? 40 didnt hold and below $ 40 in a big dip. De are aproaching to Day. What are your thoughts?

[DewDiligence]

Q&A with AAVL’s management team: #msg-113974997.

[lgonber]

I was thinking the same if gets to $45

[GuTA]

Depends on how it's trading. $40 could show some resistance , but if not I'll consider taking some profit at 45 and let the rest sit through the data release

[lgonber]

at what pps would you consider to sell some (before data)?

[GuTA]

I understand in CLDN... Rough beat there. It's part of the reason cheaper shares came available in the other gt tickers like this one. That said, I think this is a bit of a safer situation here. I also dont look gift horses in the mouth. I'll take profit along the way. I like buying in thirds and taking profits in thirds. My position is rounded out after 3 buys, and I'll happily take profits as they come..

[lgonber]

I actually bought more and doubled my position at 34.80$ (previous I have at 38$). I have not decided yet if I will hold through data. After CLDN bad data, I can only be cautious. What is your take on recent insider sales?

[GuTA]

Bought at 40.25, nibbled again at 35, loaded the boat under 30. Now I sit and wait. I've rounded out my position... Avg cost basis is now a shade under $35. Going to hold through the release of the next clinical trial results early this summer. If it maintains the course from the last results this stock will blow through 45 and head back towards the $60 mark.

Could see a natural pull back towards 33-35 between now and then, but nothing to be alarmed about

[lgonber]

AAVL. the stock went down after your purchase. Are you still on it? what are your thoughts?

[GuTA]

Can't believe we don't have a following here. 60+ by end of summer if next release of data maintains current trajectory. Bought my starter position at 40.25 Friday.

AAVL

[DewDiligence]

AAVL has preclinical program to restore color vision: #msg-112081132.

[RealGenius]

AVA 101 data from P2 wet AMD due mid 2015.